Biopharmaceuticals: Approvals and Approval Trends in 2004 - Twelve biopharmaceuticals gained marketing approval in the US and EU in 2004. Antibody-based products represented the single largest product

home: :

rss feeds/xml

Email Print

Save License

Biopharmaceuticals: Approvals and Approval Trends in 2004

Twelve biopharmaceuticals gained marketing approval in the US and EU in 2004. Antibody-based products represented the single largest product category.

May 1, 2005
By: Gary Walsh, PhD
BioPharm International
Volume 18, Issue 5

« Previous

1 2 3 4 56

5 Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu. Rev. Med. 2005; 56: 555-583.

6 US Food and Drug Administration Home Page. Available at http://www.fda.gov/.

7 European Medicines Agency Home Page. Available at http://www.emea.eu.int/.

« Previous

1 2 3 4 56

blog comments powered by Disqus

About the Author

Gary Walsh, PhD

gary.walsh@ul.ie

Associate Professor in the Industrial Biochemistry Program at the University of Limerick. He is also a member of BioPharm International's Editorial Advisory Board. Articles by Gary Walsh, PhD